Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India
利妥昔单抗生物类似药治疗弥漫性大B细胞淋巴瘤:一项在印度开展的3期随机研究
期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-023-04530-x
Patel, Ankit; Bhatt, Niraj; Prakash, S S; Biswas, Ghanashyam; Nagarkar, Rajnish; Roy, Bodhisatta; Samal, Priyanka; Agrawal, Narendra; Meshram, Sushil; Kaushal, Ashish; Satheesh, C T; Wategaonkar, Ravikumar; Thiagarajan, Kasi Viswanathan; Jain, Kartikeya; Vijayaveeran, P; Mukherjee, Kalyan; Singh, Kishore; Patil, Tushar; Jain, Amit; Dolai, Tuphan Kanti; Jain, Minish; Hingmire, Sachin; Gupta, Tara Chand; Lakshmaiah, K C; Rajamanickam, Deepan; Nemade, Bhushan; Goyal, Vikash; Mahato, Pinaki; Mendiratta, Sanjeev Kumar; Doshi, Maulik